Because of this, numerous studies have been conducted to investigate the role of MIF in diseases, particularly autoimmune disorders such as rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE) where GC therapy is required [8]. Here, MIF is linked to systemic lupus erythematosus.